A multicenter phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15520 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15520-15520 ◽

Author(s):

J. Kim ◽

H. Song ◽

Y. Do ◽

M. Kim ◽

K. Lee ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

Squamous Cell Esophageal Cancer

Download Full-text

A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1130-6 ◽

2009 ◽

Vol 66 (1) ◽

pp. 31-36 ◽

Author(s):

Jin Young Kim ◽

Young Rok Do ◽

Keon Uk Park ◽

Min Kyung Kim ◽

Kyung Hee Lee ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line Therapy ◽

Line Therapy ◽

Squamous Cell Esophageal Cancer

Download Full-text

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(01)81497-0 ◽

2001 ◽

Vol 37 ◽

pp. S272 ◽

Author(s):

C. Twelves ◽

C. Butts ◽

J. Cassidy ◽

Th. Conroy ◽

F. DeBraud ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Preliminary Results ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

International Multicenter

Download Full-text

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Oncology ◽

10.1159/000350841 ◽

2013 ◽

Vol 85 (1) ◽

pp. 44-52 ◽

Author(s):

Chih-Hung Hsu ◽

Yoon Koo Kang ◽

Tsai-Shen Yang ◽

Chia-Tung Shun ◽

Yu-Yun Shao ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Hepatocellular Carcinoma ◽

First Line Therapy ◽

Asian Patients ◽

Multicenter Phase ◽

Download Full-text

Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy for patients with advanced gastric cancer; first interim analysis of a randomised multicenter phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4015 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4015-4015 ◽

Author(s):

S.-E. Al-Batran ◽

J. Stöhlmacher ◽

S. Probst ◽

S. Hollerbach ◽

G. Wilhelm ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Study ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

A nonrandomized, multicenter, phase II study of S-1 with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7602 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7602-7602

Author(s):

D. V. Jones ◽

C. Zergebel ◽

K. Saito ◽

A. Sandler

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study

10.1186/s12885-015-1685-z ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Hitoshi Soda ◽

Hiromichi Maeda ◽

Junichi Hasegawa ◽

Takao Takahashi ◽

Shoichi Hazama ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

6098 POSTER CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/l-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal Cancer

European Journal of Cancer ◽

10.1016/s0959-8049(11)71743-9 ◽

2011 ◽

Vol 47 ◽

pp. S421

Author(s):

K. Ishibashi ◽

K. Koda ◽

M. Oshiro ◽

H. Matsuoka ◽

H. Baba ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Study ◽

Trial Result ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

Voice Trial-Results from a Multicenter Phase Ii Study of Assessment of Clinical Efficacy and Safety in Capecitabine Plus Intermittent Oxaliplatin Together with Bevacizumab As the First-Line Therapy for the Patients with Advanced Colorectal Cancer

Annals of Oncology ◽

10.1093/annonc/mdu333.27 ◽

2014 ◽

Vol 25 ◽

pp. iv178

Author(s):

C. Kosugi ◽

K. Koda ◽

T. Denda ◽

K. Ishibashi ◽

H. Ishida ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Clinical Efficacy ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Efficacy And Safety ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer

Anti-Cancer Drugs ◽

10.1097/cad.0b013e32830c457e ◽

2008 ◽

Vol 19 (8) ◽

pp. 825-831 ◽

Author(s):

Chaoying Liu ◽

Qing Sun ◽

Xiaosheng Hang ◽

Baoliang Zhong ◽

Daoyuan Wang

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Chinese Patients ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy

Oncology ◽

10.1159/000330194 ◽

2011 ◽

Vol 81 (1) ◽

pp. 3-8 ◽

Author(s):

F. Kullmann ◽

A. Hartmann ◽

R. Stöhr ◽

H. Messmann ◽

M.M. Dollinger ◽

...

Keyword(s):

Pancreatic Ductal Adenocarcinoma ◽

Phase Ii ◽

Kras Mutation ◽

Phase Ii Study ◽

Ductal Adenocarcinoma ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text